ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Assessing the role of IL-35 in colorectal cancer progression and prognosis

Zeng Jin Cheng; Zhang Zhi; Li Tian Yu; Liang Yan Fang; Wang Hong Mei; Bao Jing Jing; Zhang Jun Ai; Wang Wan Dang; Xiang Wen Yu; Kong Bin; Wang Zhi Yong; Wu Bin Hua; Chen Xiao Dong; He Long; Zhang Shu; Wang Cong Yi; Xu Jun Fa*广东医学院; 东莞市人民医院
International Journal of Clinical and Experimental Pathology2013
15被引9阅读
引用收藏
分享

摘要

Despite the recent realization of Interleukin (IL)-35 in tumorigenesis, its exact impact on colorectal cancer (CRC) progression and prognosis, however, is yet to be elucidated clearly. We thus in the present report conducted comparative analysis of IL-35 levels between CRC patients and matched control subjects. IL-35 is highly expressed in all CRC tissues, which can be detected in vast majority of colorectal cancer cells. IL-35 levels in CRC lysates and serum samples are highly correlated to the severity of malignancy and the clinical stage of tumor. Particularly, a significant reduction for serum IL-35 was noted in patients after surgical resection, indicating that IL-35 promotes CRC progression associated with poor prognosis. Mechanistic study demonstrated a significant correlation between serum IL-35 levels and the number of peripheral regulatory T (Treg) cells in CRC patients, suggesting that IL-35 implicates in CRC pathogenesis probably by inducing Treg cells, while cancer cell-derived IL-35 may also recruit Treg cells into the tumor microenvironment in favor of tumor growth. Together, our data support that IL-35 could be a valuable biomarker for assessing CRC progression and prognosis in clinical settings.

学科与关键词

关键词
Interleukin-35colorectal cancerregulatory T cellEBI3IL-12p35
相关
加载中…
  • Interleukin-35 expression is associated with colon cancer progression
    Zhang Jian; Mao Tao; Wang Shuyun; Wang Dongsheng; Niu Zhaojian; Sun Zhenqing; Zhang JianliONCOTARGET, 2017, 8(42): 71563-71573.
  • Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinoma
    Jin Lingwei; Xu Xiaoyan; Ye Bairu; Pan Min; Shi Zhen; Hu YunlingInternational Journal of Clinical and Experimental Medicine, 2015, 8(10): 18861-18866.
  • Clinical significance of IL-35 expression in the progression of clear cell renal cell carcinoma
    Zhang Jun; Hu Linkun; Lei Lei; Gu Yuwei; Zhang Xuefeng; Wu Kerong; Wei Xuedong; Liu Haiyan; Hou JianquanInternational Journal of Clinical and Experimental Medicine, 2017, 10(2): 2960-2966.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Clinical and Experimental Pathology
发表日期
2013
卷期
第 6 卷, 第 9 期
页码
1806-1816
语言
ENGLISH
期刊等级
Q3
成果收录
SCI
资助标注
National Natural Science Foundation of China [30971779, 81273237]; Key Project of Science and Technology Innovation of Education Department of Guangdong Province [2012KJCX0059]; Science and Technology Project of Dongguan [2012105102016, 20131051010006]; Science and Technology Innovation Fund of Guangdong Medical College [STIF201110]

作者

  • Z

    Zeng Jin Cheng (第一作者)

    guangdong med coll

  • Z

    Zhang Zhi

    guangdong med coll

查看全部 17 位作者收起作者
  • L

    Li Tian Yu

    guangdong med coll

  • L

    Liang Yan Fang

    peoples hosp dongguan

  • W

    Wang Hong Mei

    guangdong med coll

  • B

    Bao Jing Jing

  • Z

    Zhang Jun Ai

  • W

    Wang Wan Dang

    guangdong med coll

  • X

    Xiang Wen Yu

    guangdong med coll

  • K

    Kong Bin

  • W

    Wang Zhi Yong

    guangdong med coll

  • W

    Wu Bin Hua

  • C

    Chen Xiao Dong

    guangdong med coll

  • H

    He Long

  • Z

    Zhang Shu

  • W

    Wang Cong Yi

    guangdong med coll

  • X

    Xu Jun Fa (通讯)

    guangdong med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417